Biomaterials are increasingly being developed as in vitro microenvironments mimicking in vivo stem cell niches. However, current macroscale methodologies to produce these niche models fail to recapitulate the spatial and temporal characteristics of the complex native stem cell regulatory systems. Microfluidic technology offers unprecedented control over the spatial and temporal display of biological signals and therefore promises new avenues for stem cell niche engineering. Here we discuss how the two approaches can be combined to generate more physiological models of stem cell niches that could facilitate the identification of new mechanisms of stem cell regulation, profoundly impacting drug discovery and ultimately therapeutic applications of stem cells.
Introduction
Stem cell biologists begin to recognize the relevance of advanced biomaterials as tools for the study of stem cell self-renewal and differentiation. The interest in biomaterials has risen largely because of the increased awareness of the shortcomings of existing cell culture techniques to control stem cell behavior in vitro. Isolated from a tissue and exposed to a rigid and hydrophobic plastic cell culture substrate, many adult stem cell types rapidly lose their multipotent characteristics. In vivo, the stem cells reside in highly hydrated and soft niches ( Figure 1a ) that anchor the stem cell to its anatomical site in a tissue and provide instructive cues that regulate fate ( Figure 1b ) [1, 2] . Niches are typically composed of crosslinked extracellular matrices (ECMs) rich in proteins and sugars, as well as support cells that secrete short-range soluble signaling cues and provide crucial cell-cell interactions ( Figure 1a ).
The niche-dependency of stem cell fate therefore necessitates in vitro milieus that provide the key biochemical signals that need to be presented in a tissue-specific, biophysically relevant context [3, 4 ] . Indeed, new generations of biomaterials can be tailor-made to mimic the in vivo milieu of stem cells [5] [6] [7] (Figure 1c ). Recent advances allow for example the fabrication of hydrogels with precisely and to some extent independently tunable mechanical property, degradability and bioactivity (e.g. [8, 9 ]). However, despite these exciting advances, many mammalian stem cells still cannot be cultured in vitro for an extended period of time without losing their self-renewing capacity, such as has been shown for hematopoietic stem cells [10 ] or muscle stem cells [4 ] , and the differentiation of stem cells in a highly controlled fashion remains a formidable challenge, presumably because of our limited control over the spatial and temporal presentations of biological signals to stem cells in vitro.
We believe that one way to overcome this hurdle is the application of microfluidic technology to the design and modification of biomaterials. Microfluidics, that is the manipulation of nanoliters and picoliters of liquid within channels of dedicated microdevices, is characterized by laminar flow profiles and diffusive mixing. It is this unique flow regime that allows the positioning of biomolecules or cells with previously unmet precision and welldefined dynamics [11] [12] [13] . When cleverly combined with biomolecular materials, this approach thus promises the development of a panoply of miniaturized models of stem cell microenvironments or even tissues with various levels of complexity (Figure 1d) . What is more, new ways of screening artificial microenvironments in high-throughput can be envisioned (Figure 1e ).
Here we review recent efforts that have integrated biomaterials, particularly hydrogels, in microfluidics platforms (or vice versa) to study stem cells in a physiologically relevant context. Furthermore, we highlight emerging technologies that have not yet found their way to stem cell applications, but, if successfully implemented, could become powerful tools to further our understanding of stem cell biology.
Micropatterning of biomolecules and hydrogels on surfaces
In the native niche, stem cells may be exposed to graded or 'polarized' microenvironmental distributions of biomolecules such as growth factors or ECM proteins. In vitro, an asymmetric signal distribution can for example be achieved on a surface by hydrodynamic patterning, which relies on the controllable diffusive mixing in microchannels of microfluidic devices.
One the one hand, when employing a chip where diffusion is limited, hydrodynamic patterning can be directly used to stimulate cells in a spatially controlled fashion with bioactive molecules at subcellular resolution by flowing two different liquid streams over a single cell (as successfully demonstrated in classical experiments [14] ), embryonic stem cell (ESC) colonies [15] , or even individual Drosophila embryos [16] . On the other hand, by manipulating the diffusive mixing of two inlet streams, microfluidics allows the well-controlled generation of continuous gradients of soluble proteins. These microfluidic gradient generators offer higher spatial control than classical methods such as the Boyden chamber or micropipets. Consequently, numerous systems to generate gradients have been developed over the last decade (as reviewed in Ref. [17] ) and utilized, for example, to investigate the effect of various soluble growth factor gradients on neural stem cell behavior [18] .
However, most studies employing gradient makers were conducted with cells cultured on nonphysiological glass or plastic substrates. Clearly, integrating biomimetic hydrogels into such hydrodynamic patterning devices would increase their relevance. This may be achieved by simply coating a chip surface with a biomaterial of interest [15] , or by employing microfluidics to synthesize micropatterned hydrogels directly within the microchannels. To this end, step-wise photopolymerization reactions were for example used to generate cell-adhesive poly(ethylene 692 Tissue, cell and pathway engineering glycol) (PEG) substrates with defined stiffness regions to investigate directional cell migration ('durotaxis') [19 ] . Notably, at the end of the fabrication, the chip was removed and the patterned substrate was used for cell culture in a normal macroscale culture environment.
Alternatively, preformed reactive hydrogel films may be patterned by tagged biomolecules using microfluidic technology [20, 21 ] (Figure 2) . A PEG hydrogel film, covalently modified with NeutrAvidin and/or ProteinA, was for example used to capture from solution, in just a few minutes, gradients of biotinylated or Fc-tagged proteins within a microfluidic gradient maker (Figure 2a-c) . After patterning, the microfluidic chip was removed and the patterned hydrogels used for cell culture. Importantly, hydrodynamic flow focusing allowed forming, in a software-controlled fashion, gelimmobilized protein patterns with virtually any shape (Figure 2d ) [21 ] , while the orthogonality of the two affinity binding schemes enabled independent immobilization of two overlapping protein gradients (Figure 2e ). Hydrodynamic patterning of hydrogels could be applied to other elegant microfluidic techniques [22, 23] .
Micropatterning of proteins and hydrogels in three dimensions
Whereas the above two-dimensional (2D) approaches provide powerful reductionist models to study the role of the heterogeneous distribution of biomolecules in a natural stem cell niche, they omit the third dimension and, therefore, possibly an important determinant of stem cell fate. However, exciting advances have been made in generating three-dimensional (3D) artificial niches by combining microfluidics and biomaterials technology.
In one popular approach, hydrogel precursors and cells can be loaded between two channels within a microfluidic device where the hydrogel crosslinks in situ and encapsulates the cells. The channels can then be perfused to act as a source and sink of a biomolecule diffusing through the hydrogel to establish a stable gradient. In order to perfuse the system, it is obviously crucial not to obstruct the perfusion channels with the hydrogel which requires localized gelation for example via photolithography [24, 25] , micropatterning via laminar flow [26 ,27] or by physical confinement. The latter is usually achieved with narrowly spaced posts, which, when properly designed, restrict the flow of the liquid gel precursor by balancing surface tension and capillary force [28, 29, 30 ] (Figure 3 ). This chip design, which has been commercialized (e.g. Ibidi GmbH, Germany) [31] , has been successfully applied to study cells exposed to gradients in 3D gels [32, 33] . Examples include studies of neurite growth in a 3D collagen gel under a Netrin-gradient [31] , or the de novo formation of vascular capillaries under a gradient of vascular endothelial cell growth factor or sphingosine-1-phosphate [32] .
Biomicrofluidics: fabricating microchannel networks within bioactive hydrogels
Most microfluidic chips are fabricated from PDMS, because this material has favorable properties such as ease of processing and handling, permeability to gases, and elastic deformability that enables for example the integration of on-chip valves in multilayered chips. Nevertheless, as a substrate and device for applications in stem cell niche engineering, PDMS has some limitations. It rapidly adsorbs proteins, is rather difficult to biofunctionalize and does not allow the encapsulation of cells. For these reasons, researchers have sought to directly pattern microchannels within hydrogels such as alginate, agarose or gelatin [13] . These 'biomicrofluidic' devices can be readily perfused [34, 35] and at the same time can serve as scaffolds for cells [36] [37] [38] . In contrast to Biomaterials meet microfluidics: building the next generation of artificial niches Kobel and Lutolf 693 Albeit not yet frequently applied to stem cell biology, such hydrogel chips could offer exciting avenues to modulate the cellular microenvironment. Nonetheless, their current fabrication by micromolding against a PDMS template makes the fabrication of complex 3D networks or multi-layered cellular constructs difficult. In addition, reliable micromolding necessitates relatively highly crosslinked hydrogels that may not be well suited for 3D stem cell culture and the induction of a morphogenetic cellular process. One approach that could circumvent these limitations may be the use of inkjet printing to fabricate biomicrofluidic networks. Inkjet printing theoretically allows the deposition of picoliter droplets containing biomaterial precursors, cells and growth factors [39, 40] . If suitable 'bio-inks' were available, the fabrication of macroscopic, cell-containing 3D constructs based on computer-assisted designs could be envisioned. Such physiological 3D cell culture models could not only be highly relevant for basic biological studies but also for in vitro drug screening and ultimately regenerative medicine.
Microfluidic platforms for high-throughput screening of 3D artificial stem cell niches
An important impetus for the application of microfluidic technology in the context of stem cell niche engineering is its huge potential for miniaturization and therefore parallelization of experiments [41] . For example, microenvironments could be microfluidically produced in highthroughput as miniaturized cell culture systems, for screening applications or as microtissues (Figure 1e) . One approach to achieve this goal consists in the development of integrated 3D chips with on-chip microfluidic valves. Such a system has been developed containing an array of 16 individually addressable cellculture chambers that could be loaded with hydrogels and stem cells [42] .
Alternatively, microfluidic flow-through devices could be used to generate microbeads composed of hydrogels, cells and test compounds. They could be produced using stopand-flow systems [43, 44] or via microfluidic droplet generation. The latter technology relies on the injection of an aqueous solution into a stream of a carrier fluid, typically oil, inside of a microfluidic chip. Because the liquid streams are not miscible, they reproducibly emulsify at a very high frequency where the two streams meet [45] . Methodologies are emerging to produce microdroplets containing liquid gel precursors that can be crosslinked to hydrogel microbeads in the presence of cells and, if necessary, containing a tag encoding the composition of each microbead [43,46 ,47] . However, at the moment, hydrogel microbeads have mostly been fabricated from naturally derived polymers such as alginate that polymerize rapidly and are relatively dense (e.g. [48 -50] ); slowly polymerizing and soft hydrogel systems require extensive incubation channels (in flow-through system, incubation time translates into distance) [51] . This limits the use of microbead technology for some stem cell types that grow poorly in densely crosslinked hydrogel systems. Therefore, microfluidic set-ups and biomaterials will need to be further optimized to produce cell-permissive microbeads in high-throughput.
Nevertheless, over the last five years or so, microdroplet technology has progressed at an impressive pace. Microdroplets can now be reliably stored, fused, separated and analyzed [45] , and there are methods to modulate the composition of the microdroplets in high-throughput [46 ,52 ] . To this end, a microfluidic chip was developed to screen a library of eight acetylenes and 16 acids under four different conditions for click crosslinking reactions [52 ] . The 1024 combinations were prepared and mixed on the microfluidic chip in a fully automated fashion and then sequentially loaded into Teflon tubing for incubation. From there, each combination could be eluded, purified and analyzed by mass spectrometry. Intriguingly, the preparation of a single combination required only ca. 17 s. The application of similar strategies to screen for hydrogel-based stem cell microenvironments to discover functional artificial niches would be truly exciting.
A different approach was recently described to screen the effect of variable concentrations of the chematherapeutic agent mitomycine C on nonadherent cancer cells [46 ] . The authors first prepared a droplet-based library of different drug concentrations that was labeled with a fluorescent tag. This library was then loaded onto a second microfluidic chip where the droplets containing the cytotoxic compound were fused pair-wise with microdroplets containing the cells. After removing the microdroplets from the chip and incubating them for four days, the microdroplets were loaded onto a third chip and cell viability and the fluorescence tag were analyzed using spectroscopic methods.
The successful integration of hydrogel microbeads could extend such screening possibilities to adherent (stem) cell types. One could imagine either drug screens or combinatorial testing of different ECM compositions. That said, screening applications will surely not be the only application of such microbeads as they could for example be utilized as stem cell expansion carriers, building blocks for tissue constructs or implantable bio-sensors [53] [54] [55] .
Towards functional tissue models using microfluidic chips and biomaterials One of the most captivating challenges in modern tissue engineering is the in vitro reconstruction of tissue or organ function. Microfluidics is well poised to facilitate such applications. Recently, an 'artificial lung' was generated on a chip composed of an immunologically functional bilayer of endothelial and epithelial cells seeded onto the two sides of a porous PDMS membrane [56 ] . This device served as a realistic model to study the toxicity of nanoparticles by mimicking the respiration-induced deformation of the bi-layer and thus could trigger the strain-dependent uptake of nanoparticles by the epithelium.
An application of this concept to 3D tissue models, such as the bone marrow would require the integration of advanced biomaterials. We believe that most of the approaches that were discussed above could be suitable for this purpose. For example, photopolymerizable materials can easily be patterned into complex structures using photolithography [24, 25, 57] , or microfluidics can be used to assemble microtissues in a precise configuration [54] . Alternatively, microfluidically generated hydrogel microbeads might be directly used as tissue building blocks [58] in such 'tissue-on-a-chip' models.
An important challenge in the fabrication of functional artificial tissues is the adequate 3D patterning of multiple cell types into a tissue-like architecture. Microfluidics offers precise spatial control of the components of 3D co-culture systems [28, 29, 30 ]. For example, researchers have engineered a hydrogel bi-layer of hepatocytes and endothelial cells. Interestingly, the system allowed the mimicry of interstitial flow which promoted the formation of tissue-like structures by the hepatocytes [59] . Similar work has recently yielded a recapitulation of the perivascular association of mesenchymal stem cells (MSCs) [30 ] . 400-mm wide stripes of hydrogels were loaded with mesenchymal stem cells (MSCs) with human umbilical vein endothelial cells (HUVECs) seeded to the channels next to the hydrogels. Over 14 days, these endothelial cells vascularized the hydrogels, while MSCs started to form close associations with the new capillaries. Although this represents only a first step towards the in vitro recapitulation of the perivascular niche of adult stem cells, such microfabricated co-culture models could be further advanced for example by applying biomolecules gradients, or by seeding primary functional niche cells, such as Nestin + MSCs [60] , together with primary hematopoietic stem cells.
Conclusions
The fields of biomaterials engineering and microfluidics have advanced to impressive levels of sophistication. The interface of these two fields now promises truly exciting avenues for stem cell biotechnology and biology. Novel in vitro platforms to decipher the mechanism of stem cell regulation have already been generated. For example, the micropatterning of biomaterials using microfluidics has made possible the fabrication of physiological niche models in two and three dimensions. These models are able to mimic not only the asymmetric or graded distribution of key niche components but also the precise 3D arrangement of different cell types in co-culture systems. The time is ripe to expand on these pioneering efforts to further integrate biomaterials technology into microfluidic chips to tackle pertinent questions in stem cell research. The results of these efforts might have impact beyond in vitro studies into regenerative therapies of the future.
